Brief: Champions Biotechnology Reports Rise Of 14% In Qtrly Rev

Champions Oncology

16/12/2019 22:09

Dec 16 (Reuters) - Champions Biotechnology  Inc  CSBR.O :
    * CHAMPIONS BIOTECHNOLOGY - QUARTERLY REVENUE OF $7.6
MILLION, UP
14% YEAR-OVER-YEAR
    * CHAMPIONS BIOTECHNOLOGY - ANTICIPATE TO CONTINUE QUARTERLY
PROFITABILITY TREND FOR THE REMAINDER OF THE YEAR
    * CHAMPIONS BIOTECHNOLOGY - QTRLY EARNINGS PER SHARE $0.02
    * CHAMPIONS BIOTECHNOLOGY - QTRLY ADJUSTED. EARNINGS PER
SHARE
$0.03

Source text: (https://bit.ly/2S1KqXh)
Further company coverage:  CSBR.O 

 ((Reuters.Briefs@thomsonreuters.com;))